VIR
Vir Biotechnology Inc
NASDAQ: VIR · HEALTHCARE · BIOTECHNOLOGY
$10.22
+1.34% today
Updated 2026-04-30
Market cap
$1.72B
P/E ratio
—
P/S ratio
25.02x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $12
Volume
4.0M
Vir Biotechnology Inc (VIR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-74.90%
ROE
-45.70%
ROA
-24.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $149000.00 | $-69.85M | -41,854.36% | -54,695.97% | -46,880.54% |
| 2018 | $868000.00 | $-115.88M | -11,447.12% | -13,674.19% | -13,350.69% |
| 2019 | $711000.00 | $-174.68M | 100.00% | -25,032.21% | -24,568.64% |
| 2020 | $76.37M | $-298.67M | 100.00% | -388.88% | -391.09% |
| 2021 | $1.10B | $528.58M | 53.09% | 38.41% | 48.25% |
| 2022 | $1.62B | $515.84M | 61.57% | 51.56% | 31.92% |
| 2023 | $86.18M | $-615.06M | -564.69% | -794.04% | -713.69% |
| 2024 | $74.20M | $-521.96M | -545.03% | -791.27% | -703.40% |
| 2025 | $68.56M | $-437.99M | 82.92% | -682.68% | -638.87% |